Quick View
| Metric | Current Period | Same Period Last Year | YoY |
|---|---|---|---|
| Revenue | ¥0.95B | ¥0.69B | +37.6% |
| Operating Income | ¥0.16B | ¥0.04B | +252.7% |
| Ordinary Income | ¥0.16B | ¥0.05B | +244.8% |
| Net Income | ¥0.13B | ¥0.03B | +311.8% |
| ROE | 7.5% | 1.9% | - |
Executive Summary
The company posted higher revenue and earnings, with strong operating leverage driving profit growth substantially above revenue growth. Revenue was ¥0.95B (¥0.69B in the prior year, YoY +37.6%), Operating Income was ¥0.16B (¥0.04B in the prior year, YoY +252.7%), Ordinary Income was ¥0.16B (YoY +244.8%), and Net Income was ¥0.13B (YoY +311.8%). The primary factors behind the earnings growth were increased revenue resulting from expanding demand in the core segment and the associated absorption of fixed costs.
Factors Affecting Financial Performance
【Revenue】Revenue was ¥0.95B, up +37.6% year on year. By segment, the core NanoAndMicroTechnology segment led growth with revenue of ¥0.78B (82.1% of total, YoY +41.4%), followed by MacroTechnology with ¥0.17B (17.9% of total, YoY +30.0%). Other businesses remained small at ¥0.01B and contracted YoY -50.2%.
【Profit and Loss】Operating Income increased to ¥0.16B (YoY +252.7%), substantially outpacing the revenue growth rate. The gross margin improved to 45.4% (42.0% in the prior year), while the SG&A ratio was contained at 29.0%, resulting in strong operating leverage through fixed-cost absorption. Non-operating income and expenses were small (non-operating income of ¥0.004B and non-operating expenses of ¥0.001B), leaving Ordinary Income at approximately the same level as Operating Income, at ¥0.16B. Net Income was ¥0.13B (YoY +311.8%) under a low effective tax rate of 15.7%, exceeding the growth in Operating Income. The company achieved both revenue and earnings growth, confirming an improvement in its earnings structure in which profit growth substantially outpaced revenue growth.
Segment Analysis
NanoAndMicroTechnology accounted for the core of the company, with revenue of ¥0.78B (YoY +41.4%), gross profit of ¥0.38B (YoY +50.1%), and a profit margin of 49.1%. MacroTechnology generated revenue of ¥0.17B (YoY +30.0%) with a profit margin of 28.4%. Other businesses remained small, with revenue of ¥0.01B and a profit margin of 28.9%, while maintaining a certain level of profitability. Segment profit is based on gross profit and therefore differs in definition from consolidated Operating Income, which is after the deduction of SG&A expenses.
Key Financial Indicators
【Profitability】Operating Income margin of 16.3% and Net Income margin of 14.0% both improved substantially from the prior year. The structure in which the 29.0% SG&A ratio is deducted from the 45.4% gross margin has been the starting point for the expansion in profit margins.【Cash Flow Quality】Although no statement of cash flows has been disclosed, the company’s low reliance on non-operating income (interest income of ¥0.002B compared with Operating Income of ¥0.16B) indicates that most earnings are generated by the core business, suggesting high earnings quality. On the other hand, annualized inventory days were relatively long at 92 days, creating the possibility that increased inventory could lead to a time lag between earnings and cash flows.【Investment Efficiency】ROE was 7.5%. A DuPont decomposition into a Net Income margin of 14.0%, total asset turnover of 0.483x, and financial leverage of 1.11x indicates that the low turnover ratio is a constraint.【Financial Soundness】With an Equity Ratio of 89.7%, a current ratio of 742.2%, and cash and deposits of ¥1.11B, the financial base is highly conservative and financially secure.
Cash Flow Analysis
As no statement of cash flows has been disclosed, cash flow trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥1.11B, up from ¥0.99B in the prior year, reaching a level equivalent to 56.4% of total assets. Meanwhile, inventories increased to ¥0.04B from ¥0.02B in the prior year, suggesting that production and inventory build-up may have progressed alongside revenue expansion. Accounts receivable were ¥0.11B, down from ¥0.17B in the prior year, indicating that collections are progressing favorably. Investment in fixed assets also increased slightly, with property, plant and equipment at ¥0.49B compared with ¥0.46B in the prior year, indicating a gradual expansion in investment. Overall, maintaining and increasing cash levels alongside earnings growth represents favorable capital efficiency.
Earnings Quality
The growth in Net Income (YoY +311.8%) exceeded the growth in Operating Income (YoY +252.7%), requiring examination of the impact of non-operating income and expenses and the tax burden. Non-operating income was ¥0.004B and non-operating expenses were ¥0.001B, both small, indicating that most earnings are recurring income generated by the core business. The effective tax rate was approximately 15.7%, based on Income Before Tax of ¥0.159B and income taxes of ¥0.02B, a substantial decline from approximately 29.4% in the same period of the prior year. This was one factor behind Net Income growth exceeding Operating Income growth. Extraordinary gains and losses have not been disclosed, and any earnings boost from temporary factors appears limited. The increase in inventories could generate future accruals (a discrepancy between accounting earnings and cash), making it an item to monitor when assessing earnings sustainability.
Earnings Forecast and Guidance
Progress against the full-year forecast was 73.6% for Revenue, 93.9% for Operating Income, 94.0% for Ordinary Income, and 118.8% for Net Income. Although Revenue was slightly below the standard progress level of 75%, progress in both Operating Income and Ordinary Income exceeded the standard by approximately 19 points, while Net Income had already exceeded the full-year forecast by 18.8%. This difference was primarily attributable to the decline in the effective tax rate, and the final level of Net Income achievement for the full year may vary depending on the sustainability of the tax burden. The company did not revise its forecasts as of the announcement of these results, including its dividend forecast.
Shareholder Returns
The full-year dividend forecast is ¥4.00 per share. As the Q2 dividend is ¥0, a year-end lump-sum dividend is assumed. Based on forecast full-year Net Income of ¥0.112B and forecast EPS of ¥19.80, the Payout Ratio is approximately 20.2%, indicating a light dividend burden relative to earnings. Treasury shares totaled only 208 shares, and no share repurchases were confirmed; therefore, there is no need to calculate the Total Return Ratio. Given cash and deposits of ¥1.11B and an Equity Ratio of 89.7%, the company’s ability to pay dividends is itself at a high level.
Risk Factors
-
Inventory accumulation risk: Inventories increased to ¥0.04B, up +91.4% year on year, and annualized inventory days have lengthened to approximately 92 days. While this may be temporary inventory built in anticipation of increased production, a slowdown in demand could result in valuation losses or deterioration in profit margins due to inventory adjustments.
-
Earnings concentration risk: The NanoAndMicroTechnology segment accounts for 82.1% of revenue, creating a structure in which the segment’s growth (YoY +41.4%) determines overall company performance. Dependence on a specific business area is high, increasing the impact of demand fluctuations.
-
Structural capital efficiency risk: Cash and deposits account for 56.4% of total assets, constraining total asset turnover of 0.483x and ROE (7.5%). Financial leverage is low at 1.11x, and the manner in which surplus funds are utilized will determine the future trajectory of capital efficiency.
Industry Benchmark (Reference; Company Analysis)
Industry Benchmark (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income margin | 16.3% | 8.6% (4.3%–12.7%) | +7.7pt |
| Net Income margin | 14.0% | 6.4% (2.8%–10.3%) | +7.6pt |
Both the Operating Income margin and Net Income margin substantially exceeded the industry median, placing the company in the top-tier group.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue growth rate (year on year) | 37.6% | 3.3% (-2.1%–8.9%) | +34.3pt |
The Revenue growth rate substantially exceeded the industry median, placing the company among the high-growth group within the industry.
※Source: Compiled by the company
Key Takeaways from the Earnings Results
-
Operating leverage was confirmed, with Operating Income growing YoY +252.7%, substantially above Revenue growth of YoY +37.6%. The Operating Income margin of 16.3% and Net Income margin of 14.0% were both substantially above the industry median.
-
Progress against the full-year forecast was 93.9% for Operating Income and 118.8% for Net Income, confirming upside on the earnings front. However, as this includes the impact of the decline in the effective tax rate, the sustainability of recurring earnings levels warrants further confirmation in future quarters.
-
Annualized inventory days were approximately 92 days due to the increase in inventories. The extent to which inventory normalizes will be a key point in evaluating future cash-generating capacity.
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the company based on publicly available earnings data. Investment decisions should be made at your own responsibility, after consulting professionals as necessary.
---End of Report---
AI Financial Analysis
Executive Summary
FY2026 Q3 performance was markedly ahead of the company’s full-year earnings plan, led by strong sales growth and substantial operating leverage. Cumulative Q3 revenue rose 37.6% year on year to ¥949 million. Operating income increased 252.7% to ¥155 million, while ordinary income rose 244.8% to ¥158 million. Net income grew 311.8% to ¥133 million. Gross profit increased to ¥430 million from ¥290 million in the prior-year period. The gross margin expanded by approximately 340 basis points year on year to 45.4%. The operating margin expanded by approximately 990 basis points to 16.3%, exceeding the 15% excellent-profitability benchmark. The net margin improved by approximately 940 basis points to 14.0%. SG&A expenses rose only about 11.9%, materially below revenue growth, demonstrating favorable operating leverage. Net income was supported primarily by operating performance rather than non-operating items, as non-operating income was only ¥4 million. Interest income of ¥2 million was the principal disclosed non-operating contributor, while interest expense was negligible. The effective tax rate was 15.7%, producing a favorable tax burden factor of 0.838. Q3 revenue has reached 73.6% of the ¥1.29 billion full-year forecast, broadly consistent with the standard 75% seasonal progress rate. However, operating income has already reached 93.9% of the full-year plan and net income has reached 118.8%, indicating that the earnings forecast assumes a sharp Q4 deceleration or retains substantial conservatism. The balance sheet remains exceptionally liquid, with cash and deposits of ¥1.108 billion and equity representing 89.7% of total assets. The principal operating watchpoint is inventory intensity, with annualized DIO of 92 days exceeding the 90-day warning threshold. Management’s ability to convert elevated inventory into Q4 sales while protecting the newly improved gross margin will be central to the durability of this earnings step-up.
Profitability Analysis
Annualized DuPont ROE is 10.1%, composed of a 14.0% net profit margin, 0.644x asset turnover, and 1.11x financial leverage. The largest contributor to returns is the sharp improvement in profitability rather than leverage, as the capital structure remains conservatively financed. Revenue growth of 37.6% materially outpaced the approximately 11.9% increase in SG&A expenses, creating strong operating leverage. Gross margin rose to 45.4% from approximately 42.0% in the prior-year period, a gain of about 340 basis points. This gross-profit expansion, combined with controlled overhead growth, lifted the operating margin to 16.3% from approximately 6.4%, an expansion of about 990 basis points. Net margin increased to 14.0% from approximately 4.6%, reflecting the operating recovery and a favorable tax burden. The 5-factor analysis also indicates limited financing drag: the interest burden was 1.024 and interest coverage was 906.43x. Financial leverage of 1.11x is low, so the 10.1% annualized ROE is generated predominantly through operating profitability rather than balance-sheet gearing. The current margin level appears operationally supported because ordinary income of ¥158 million was close to operating income of ¥155 million. With non-operating income equal to only 0.4% of revenue, earnings are not materially dependent on below-the-line gains. Sustainability nevertheless depends on whether the current gross-margin uplift can be retained as sales growth normalizes and elevated inventories are worked down.
Growth Assessment
Revenue growth of 37.6% to ¥949 million demonstrates a substantial acceleration from the prior-year Q3 level. Gross profit grew 48.6%, faster than sales, confirming that growth was accompanied by improved unit economics rather than being purchased through margin concessions. Operating income growth of 252.7% substantially exceeded revenue growth, reflecting a strong fixed-cost absorption effect. The full-year sales forecast of ¥1.29 billion implies that Q4 revenue would be approximately ¥341 million, broadly comparable with the average quarterly revenue run rate achieved through Q3. In contrast, the full-year operating-income forecast of ¥165 million implies only approximately ¥10 million of Q4 operating income after ¥155 million in Q3 cumulative results. The net-income forecast of ¥112 million is already below reported Q3 cumulative net income of ¥133 million, implying an approximately ¥21 million Q4 net loss under unchanged guidance. This unusually conservative implied Q4 profile makes forecast revision potential and the reasons for management’s caution important monitoring items. Inventory accumulation may reflect preparation for demand, but it also raises the risk that production or procurement has moved ahead of shipments. The increase in raw materials to ¥85 million, alongside work in process of ¥45 million and finished goods of ¥44 million, suggests inventory is distributed across the production cycle. The company’s manufacturing outlook therefore depends on converting this inventory into revenue without requiring discounting or incurring inventory valuation charges.
Financial Health
Financial health is very strong. The current ratio is 742.2% and the quick ratio is 719.4%, both far above conventional liquidity thresholds. Current assets of ¥1.424 billion exceed current liabilities of ¥192 million by ¥1.232 billion. Cash and deposits of ¥1.108 billion alone cover current liabilities by approximately 5.8x. The debt-to-equity ratio is only 0.11x, and total liabilities of ¥202 million represent just 10.3% of total assets. Noncurrent liabilities are limited to ¥10 million, including lease obligations of approximately ¥6 million. Accordingly, there is no evident maturity mismatch between short-term obligations and liquid assets. Equity increased to ¥1.762 billion from ¥1.651 billion in the prior-year period, supported by retained earnings growth of 27.4% to ¥516 million. Accounts receivable declined 30.8% to ¥115 million despite revenue growth, which is favorable for collection risk and working-capital discipline. Reported finished-goods inventories increased 91.5% to ¥44 million, while raw materials and work in process were ¥85 million and ¥45 million, respectively; the inventory build requires close operational monitoring. PPE totaled ¥494 million, or 25.2% of assets, indicating a moderate manufacturing asset base, while intangible assets were only 0.8% of assets. No goodwill-related impairment exposure was reported.
Notable B/S Changes
Inventories: ¥23 million to ¥44 million (+91.5%) - reported finished-goods inventory increased sharply; together with annualized DIO of 92 days, this raises stock-conversion, markdown, and valuation-risk considerations. Accounts receivable: ¥166 million to ¥115 million (-30.8%) - receivables declined despite 37.6% revenue growth, supporting collection discipline and potentially improving operating cash conversion. Retained earnings: ¥405 million to ¥516 million (+27.4%) - strong cumulative profitability increased internally generated capital and reinforced the already conservative balance sheet.
Cash Flow Quality
Operating cash flow and free cash flow were not reported in the provided financial statements, so cash conversion and free-cash-flow coverage cannot be quantified. Balance-sheet movements nevertheless provide mixed indicators for cash realization. Accounts receivable fell by ¥51 million year on year to ¥115 million while revenue increased 37.6%, which is supportive of cash collection. Conversely, annualized inventory days of 92 exceed the 90-day warning threshold and indicate more cash tied up in stock than is desirable. This quality alert is material because extended inventory holding periods can lead to slower cash conversion, price markdown risk, or inventory valuation pressure if demand does not materialize as expected. The inventory increase is notable in the context of strong reported earnings because an inventory build can defer some cash outflow recognition in operating cash flow until inventory is sold. The company’s substantial cash balance of ¥1.108 billion provides a strong liquidity buffer against this working-capital risk. Profit quality at the income-statement level remains favorable because operating income accounts for nearly all ordinary income and non-operating income is immaterial. There were no material extraordinary losses, with loss on retirement of noncurrent assets only ¥33 thousand. Future assessment should focus on whether inventory days normalize and whether operating cash flow keeps pace with earnings.
Dividend Sustainability
The full-year forecast specifies annual DPS of ¥4.00. Against forecast EPS of ¥19.80, the implied dividend-only payout ratio is approximately 20.2%, comfortably below the 60% sustainability benchmark. The Q2 DPS was ¥0, consistent with a year-end-oriented distribution structure. The low forecast payout ratio, cash and deposits of ¥1.108 billion, and debt-to-equity ratio of 0.11x indicate substantial balance-sheet capacity to maintain the planned dividend. Retained earnings of ¥516 million also increased from ¥405 million in the prior-year period. There is no indication of a meaningful share-repurchase program, as treasury shares remained minimal and unchanged at 208 shares. The key determinant of dividend capacity is not leverage but the conversion of profits and inventories into cash. The planned dividend appears modest relative to the current earnings base, although the gap between Q3 cumulative EPS of ¥23.50 and full-year forecast EPS of ¥19.80 underscores management’s cautious implied Q4 outlook.
Risk Assessment
Business risks include Inventory management risk: annualized DIO of 92 days is above the 90-day warning threshold. For a manufacturer, prolonged holding periods elevate the risk of slower sell-through, inventory write-downs, and margin pressure if demand weakens., Margin sustainability risk: the operating margin expanded by about 990 basis points year on year to 16.3%. A reversal in product mix, input costs, or pricing could reduce the exceptional operating leverage currently embedded in earnings., Manufacturing demand and supply-chain risk: the company holds ¥85 million of raw materials, ¥45 million of work in process, and ¥44 million of finished goods. Changes in customer demand, material prices, or production schedules could affect inventory conversion and gross profit..
Financial risks include Forecast execution risk: operating income has reached 93.9% of the full-year forecast and net income has reached 118.8% by Q3. The unchanged forecast implies an unusually weak Q4, making the timing and reliability of the earnings outlook a key uncertainty., Working-capital risk: while receivables improved, the inventory build could absorb cash and weaken operating cash conversion if stock does not translate into near-term sales., Low leverage limits financing risk: debt-to-equity is 0.11x, current ratio is 742.2%, and interest coverage is 906.43x, substantially mitigating refinancing and interest-rate exposure..
Key concerns include Highest priority: the 92-day inventory cycle should be monitored against shipment growth, gross-margin retention, and any subsequent inventory valuation adjustments., High priority: clarification of the conservative full-year forecast is needed because cumulative Q3 net income already exceeds the full-year target by 18.8%., Moderate priority: the earnings improvement is high quality at the income-statement level, but confirmation through operating cash flow is important for evaluating durability., Industry-specific priority: as a manufacturer, the company remains exposed to raw-material cost changes, production efficiency, quality-control requirements, and potential inventory obsolescence..
Investment Implications
Key takeaways include Revenue grew 37.6% year on year, while operating income grew 252.7%, evidencing powerful operating leverage., Gross margin improved to 45.4% and operating margin to 16.3%, placing current profitability above the stated excellent benchmark., Annualized ROE of 10.1% is achieved with very low financial leverage of 1.11x and D/E of 0.11x., Liquidity is exceptionally strong, supported by ¥1.108 billion of cash and a 742.2% current ratio., Inventory days of 92 are the principal disclosed quality alert and require monitoring despite otherwise favorable receivables trends., Q3 cumulative operating and net income are substantially ahead of the unchanged full-year forecast, creating unusually conservative implied Q4 assumptions..
Metrics to watch include Inventory days and the balance among raw materials, work in process, and finished goods, Q4 revenue conversion and gross-margin retention, Any revision to the ¥1.29 billion revenue, ¥165 million operating-income, and ¥112 million net-income forecasts, Operating cash flow relative to net income and inventory investment, Accounts receivable trends following the Q3 reduction to ¥115 million, FY2026 DPS execution versus the planned ¥4.00 per share.
Regarding relative positioning, The company combines above-benchmark current operating and net margins with a highly conservative balance sheet. Its annualized 10.1% ROE is solid but below the 15% excellent benchmark because returns are generated with minimal leverage. Relative to typical manufacturing risk profiles, liquidity and solvency are clear strengths, whereas the 92-day inventory cycle is the principal operational weakness requiring validation.